Patent · US Active

AMPK activators

US11407768B2 · kind B2 · utility

0Cited by
7References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 25, 2021
Grant dateAug 9, 2022
Priority date—
Expiry dateJun 25, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07F9/6561
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This disclosure is directed, at least in part, to AMPK activators useful for the treatment of conditions or disorders associated with AMPK. In some embodiments, the condition or disorder is associated with the gut-brain axis. In some embodiments, condition or disorder is associated with systemic infection and inflammation from having a leaky gut barrier. In some embodiments, the AMPK activators are gut-restricted compounds. In some embodiments, the AMPK activators are agonists, super agonists, full agonists, or partial agonists.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.